Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
Conditions
- COVID-19 Infection
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER: Survey Administration
Sponsor
University of California, San Francisco